News

Filter

Current filters:

ResearchVaccines

1 to 9 of 166 results

NewLink earns $20 million Ebola vaccine milestone from Merck

19-02-2015

US biotech firm NewLink Genetics says it had received notification from pharma giant Merck & Co that…

BiotechnologyFinancialMerck & CoNewLink GeneticsResearchTropical diseasesVaccines

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

27-01-2015

While current treatments for Alzheimer’s disease are only able to ease symptoms temporarily, tau-based…

AC ImmuneBiotechnologycrenezumabEli LillygantenerumabJohnson & JohnsonMarkets & MarketingNeurologicalResearchRochesolanezumabVaccines

Milestone for GSK/NIH candidate Ebola vaccine as first doses shipped for Phase III trial

Milestone for GSK/NIH candidate Ebola vaccine as first doses shipped for Phase III trial

23-01-2015

UK pharma major GlaxoSmithKline said this morning that the first batch of its candidate Ebola vaccine…

EbolaGlaxoSmithKlinePharmaceuticalResearchUKVaccines

Janssen among groups in Innovative Medicines Initiative consortia to accelerate Ebola program

Janssen among groups in Innovative Medicines Initiative consortia to accelerate Ebola program

19-01-2015

US health care giant Johnson & Johnson’s Europe-based subsidiary has formed consortia with several…

Anti-viralsEuropeJanssenPharmaceuticalResearchVaccines

Health management program from Practice Fusion and Merck encourages vaccine uptake

Health management program from Practice Fusion and Merck encourages vaccine uptake

16-01-2015

Cloud-based electronic record service Practice Fusion and pharma giant Merck & Co have collaborated on…

MedicineMerck & CoPractice FusionResearchVaccines

Merck & Co inks discovery and development deal with Moderna

Merck & Co inks discovery and development deal with Moderna

13-01-2015

Privately-held Moderna Therapeutics has entered into a license and collaboration agreement with US pharma…

Anti-viralsBiotechnologyFinancialMerck & CoModerna TherapeuticsResearchUSAVaccines

Janssen begins Phase I trial of its Ebola vaccine

Janssen begins Phase I trial of its Ebola vaccine

07-01-2015

US health care giant Johnson & Johnson’s Europe-based subsidiary Janssen has begun a first-in-human…

Ebola vaccineJanssenResearchUKVaccines

1 to 9 of 166 results

COMPANY SPOTLIGHT

Menarini

Back to top